Publication | Open Access
Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases
19
Citations
38
References
2019
Year
Aldo-keto ReductaseOncogenic AgentMedicineOncogenic Ep300PharmacologyRadiation OncologyCancer ResearchTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1